imported>Brinkery |
imported>Bestem |
| Line 1: |
Line 1: |
| ==Quellen== | | ==Quellen== |
| <span style="mso-list:Ignore">1. <span style="font:7.0pt "Times New Roman""> </span></span>Infective endocarditis in adults: diagnosis, antimicrobial therapy and management of complications: a scientific statement for healthcare professionals from the American Heart Association; Circulation (2015); 132(15):1435
| | 1. AATS Surgical Treatment of Infective Endocarditis Consensus Guidelines Writing Committee Chairs, Pettersson GB, Coselli JS, et al. 2016 The American Association for Thoracic Surgery (AATS) consensus guidelines: Surgical treatment of infective endocarditis: Executive summary. J Thorac Cardiovasc Surg. 2017;153(6):1241-1258.e29. doi:10.1016/j.jtcvs.2016.09.093 |
|
| |
|
| <span style="mso-list:Ignore">2. <span style="font:7.0pt "Times New Roman""> </span></span>2015 ESC Guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European society of cardiology (ESC); European Heart Journal (2015); 36(44):3075-3128
| | 2. Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016;387(10021):882-893. doi:10.1016/S0140-6736(15)00067-7 |
|
| |
|
| <span style="mso-list:Ignore">3. <span style="font:7.0pt "Times New Roman""> </span></span>The American Association for Thoracic Surgery (AATS) consensus guidelines: Surgical treatment of infective endocarditis: Executive Summary; The Journal of Thoracic and Cardiovascular Surgery (2017); 153(6):1241
| | 3. Duval X, Delahaye F, Alla F, et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol. 2012;59(22):1968-1976. doi:10.1016/j.jacc.2012.02.029 |
|
| |
|
| <span style="mso-list:Ignore">4. <span style="font:7.0pt "Times New Roman""> </span></span>2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.Heart Rhythm. 2017 Dec;14(12):e503-e551
| | 4. Duval X, Le Moing V, Tubiana S, et al. Impact of Systematic Whole-body 18F-Fluorodeoxyglucose PET/CT on the Management of Patients Suspected of Infective Endocarditis: The Prospective Multicenter TEPvENDO Study. Clin Infect Dis. 2021;73(3):393-403. doi:10.1093/cid/ciaa666 |
|
| |
|
| <span style="font-size:8.0pt;mso-bidi-font-size:11.0pt;font-family:"Calibri",sans-serif;
| | 5. Fusco FM, Pisapia R, Nardiello S, Cicala SD, Gaeta GB, Brancaccio G. Fever of unknown origin (FUO): which are the factors influencing the final diagnosis? A 2005–2015 systematic review. BMC Infectious Diseases. 2019;19(1):653. doi:10.1186/s12879-019-4285-8 |
| mso-fareast-font-family:Calibri"><span style="mso-list:Ignore">5. <span style="font:7.0pt "Times New Roman""> </span></span></span>Focaccia Siciliano R, Azevedo Randi B, Menosi Gualandro D et al: Early-onset prosthetic valve endocarditis definition revisited: Prospective study and literature review. Int J Inf Dis 2018, 67: 3-6.
| |
|
| |
|
| <span style="font-size:8.0pt;mso-bidi-font-size:11.0pt;font-family:"Calibri",sans-serif;
| | 6. Kusumoto FM, Schoenfeld MH, Wilkoff BL, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;14(12):e503-e551. doi:10.1016/j.hrthm.2017.09.001 |
| mso-fareast-font-family:Calibri"><span style="mso-list:Ignore">6. <span style="font:7.0pt "Times New Roman""> </span></span></span>POET - partial oral treatment of left-sided infectious endocarditis; Ivesen K et al. <span style="color: #222222">N Engl J Med. 28. August 2018. </span>[https://doi.org/10.1056/NEJMoa1808312 <span style="font-size:8.0pt;mso-bidi-font-size:10.0pt;font-family:"Calibri",sans-serif;
| |
| mso-fareast-font-family:Calibri;letter-spacing:.4pt;background:white;
| |
| mso-highlight:white">https://doi.org/10.1056/NEJMoa1808312</span>]
| |
|
| |
|
| <span style="font-size:8.0pt;mso-bidi-font-size:11.0pt;font-family:"Calibri",sans-serif;
| | 7. Selton-Suty C, Célard M, Le Moing V, et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012;54(9):1230-1239. doi:10.1093/cid/cis199 |
| mso-fareast-font-family:Calibri"><span style="mso-list:Ignore">7. <span style="font:7.0pt "Times New Roman""> </span></span></span>Cahill TJ, Prendergast BD: Infective Endocarditis. <span style="color: #222222">Lancet 2016; 387:882-93.</span>
| |
|
| |
|
| <span style="font-size:8.0pt;mso-bidi-font-size:11.0pt;font-family:"Calibri",sans-serif;
| | 8. Siciliano RF, Randi BA, Gualandro DM, et al. Early-onset prosthetic valve endocarditis definition revisited: Prospective study and literature review. Int J Infect Dis. 2018;67:3-6. doi:10.1016/j.ijid.2017.09.004 |
| mso-fareast-font-family:Calibri"><span style="mso-list:Ignore">8. <span style="font:7.0pt "Times New Roman""> </span></span></span>Duval et al.: <span style="mso-font-kerning:18.0pt;mso-bidi-font-weight:bold">Impact of Systematic Whole-body 18F-Fluorodeoxyglucose PET/CT on the Management of Patients Suspected of Infective Endocarditis: The Prospec''tive Multicenter TEPvENDO Study. ''</span><span style="font-size:8.0pt;font-family:"Calibri",sans-serif;mso-ascii-theme-font:
| |
| minor-latin;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:"Times New Roman"">Clin Infect Dis 2021 Aug 2;73(3):393-403.</span>
| |
|
| |
|
| <span style="mso-list:Ignore">9. <span style="font:7.0pt "Times New Roman""> </span></span><span style="color: #333333">Fusco, F.M., Pisapia, R., Nardiello, S. ''et al.'' Fever of unknown origin (FUO): which are the factors influencing the final diagnosis? A 2005–2015 systematic review. ''BMC Infect Dis'' '''19,''' 653 (2019). </span>[https://doi.org/10.1186/s12879-019-4285-8 <span style="font-size:8.0pt;
| | 9. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association - PubMed. Accessed March 15, 2022. <nowiki>https://pubmed.ncbi.nlm.nih.gov/26373316/</nowiki> |
| font-family:"Calibri",sans-serif;mso-ascii-theme-font:minor-latin;mso-hansi-theme-font:
| |
| minor-latin;mso-bidi-font-family:"Segoe UI";background:white">https://doi.org/10.1186/s12879-019-4285-8</span>]
| |
|
| |
|
| <span style="mso-list:Ignore">10. <span style="font:7.0pt "Times New Roman""> </span></span><span style="color: #212121">Selton-Suty C, Célard M, Le Moing V, Doco-Lecompte T, Chirouze C, Iung B, Strady C, Revest M, Vandenesch F, Bouvet A, Delahaye F, Alla F, Duval X, Hoen B; AEPEI Study Group. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012 May;54(9):1230-9. doi: 10.1093/cid/cis199. PMID: 22492317.</span>
| | 10. Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis | NEJM. Accessed March 15, 2022. <nowiki>https://www.nejm.org/doi/10.1056/NEJMoa1808312</nowiki> |
| | | <br /> |
| <span style="color: #212121"><span style="mso-list:Ignore">11. <span style="font:7.0pt "Times New Roman""> </span></span></span><span style="color: #212121">Duval X, Delahaye F, Alla F, Tattevin P, Obadia JF, Le Moing V, Doco-Lecompte T, Celard M, Poyart C, Strady C, Chirouze C, Bes M, Cambau E, Iung B, Selton-Suty C, Hoen B; AEPEI Study Group. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol. 2012 May 29;59(22):1968-76. doi: 10.1016/j.jacc.2012.02.029. PMID: 22624837.</span>
| |
Quellen
1. AATS Surgical Treatment of Infective Endocarditis Consensus Guidelines Writing Committee Chairs, Pettersson GB, Coselli JS, et al. 2016 The American Association for Thoracic Surgery (AATS) consensus guidelines: Surgical treatment of infective endocarditis: Executive summary. J Thorac Cardiovasc Surg. 2017;153(6):1241-1258.e29. doi:10.1016/j.jtcvs.2016.09.093
2. Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016;387(10021):882-893. doi:10.1016/S0140-6736(15)00067-7
3. Duval X, Delahaye F, Alla F, et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol. 2012;59(22):1968-1976. doi:10.1016/j.jacc.2012.02.029
4. Duval X, Le Moing V, Tubiana S, et al. Impact of Systematic Whole-body 18F-Fluorodeoxyglucose PET/CT on the Management of Patients Suspected of Infective Endocarditis: The Prospective Multicenter TEPvENDO Study. Clin Infect Dis. 2021;73(3):393-403. doi:10.1093/cid/ciaa666
5. Fusco FM, Pisapia R, Nardiello S, Cicala SD, Gaeta GB, Brancaccio G. Fever of unknown origin (FUO): which are the factors influencing the final diagnosis? A 2005–2015 systematic review. BMC Infectious Diseases. 2019;19(1):653. doi:10.1186/s12879-019-4285-8
6. Kusumoto FM, Schoenfeld MH, Wilkoff BL, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;14(12):e503-e551. doi:10.1016/j.hrthm.2017.09.001
7. Selton-Suty C, Célard M, Le Moing V, et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012;54(9):1230-1239. doi:10.1093/cid/cis199
8. Siciliano RF, Randi BA, Gualandro DM, et al. Early-onset prosthetic valve endocarditis definition revisited: Prospective study and literature review. Int J Infect Dis. 2018;67:3-6. doi:10.1016/j.ijid.2017.09.004
9. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association - PubMed. Accessed March 15, 2022. https://pubmed.ncbi.nlm.nih.gov/26373316/
10. Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis | NEJM. Accessed March 15, 2022. https://www.nejm.org/doi/10.1056/NEJMoa1808312
